Social networks: Readers respond
Few topics of this newsletter hit a nerve as sharply as social networking has. In fact, I get more mail when I write on this topic than I seem to receive on all other topics combined. (Something I suppose I should keep in mind when things get a little lonely in my office.) Last week, I wrote tha...New book from former CDC CEO walks readers through innovation
MINNEAPOLIS - I recently interviewed Robert M. Price about his book "The Eye For Innovation: Recognizing Possibilities and Managing the Creative Enterprise". This column includes his comments about business, strategy, innovation and "the `C' word". "At its most basic level," he writes, "busines...HTRF IP-One Assay Performed on the PHERAstar and RUBYstar Plate Readers
Marjan Orban 1 , Francois Degorce 2 and Jean-Luc Tardieu 2 1 BMG LABTECH, Germany; 2 Cisbio international, France Application Note 137 Rev. 12/2005 HTRF IP-One ...Insmed to Host Second Quarter 2009 Conference Call
...tailed in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2008. readers are cautioned not to place undue reliance on any forward-looking statements which speak only as of the date of this release. We undertake no obligatio...ERT Reports Second Quarter 2009 Results
...ng statements, to reflect the events or circumstances arising after the date as of which they were made. As a result of these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements included in this release or that may be made in our filings with the Secur...Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009
...AP measure, it will provide a reconciliation of non-GAAP financial measures to the most closely applicable GAAP financial measure. Investors and other readers are encouraged to review the related GAAP financial measures and the reconciliation of non-GAAP measures to their most closely applicable GAAP measure...RadMD First to Offer CME-Certified Education and Training For Medical Imaging in Clinical Trials
... programs, education and training through BRITI (the Blinded Reader & Investigator Training Institute), and the sourcing and management of blinded readers for clinical trials. BRITI is a trademark of RadMD Inc. This release, and additional RadMD resources, is available online in the Feintu...Zimmer Launches New Medical Education and BioSkills Training Program
...y forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports. readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the f...Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
...rterly report for the three months ended March 31, 2009 filed with the SEC on Form 10-Q. Given these uncertainties, assumptions and risk factors, readers are cautioned not to place undue reliance on such forward-looking statements. Except as required by law, we disclaim any obligation to update any such...Neogen Reports 16% Increase in Revenues
... deoxynivalenol (DON) improved by 10% compared to the prior year. Sales of Neogen products that require a capital investment, including AccuPoint((R)) readers and Soleris((TM)) microbial detection instruments, slowed in 2009 due to the impact of the economic downturn. However, sales of associated disposable ...Derma Sciences, Inc. Hires the Investor Relations Group
... as "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forwar...Anthony Hess to Lead SAIC Health Solutions Business Unit
...0-K for the period ended January 31, 2009, and other such filings that SAIC makes with the SEC from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. Contact: Mel...Angiotech Pharmaceuticals announces FDA approval of TAXUS(R) Liberte(R) Long Stent
...quarterly report for the three months ended March 31, 2009 filed with the SEC on Form 10-Q. Given these uncertainties, assumptions and risk factors, readers are cautioned not to place undue reliance on such forward-looking statements. Except as required by law, we disclaim any obligation to update any such...China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results
... or "continue," the negative of such terms or other comparable terminology. readers should not rely on forward-looking statements as predictions of future even... implied in the forward-looking statements. In evaluating these statements, readers should consider various factors, including the risks described in "Item 1A....Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009
...of and future demand for Santaris Pharma products and the impact of competitive products and pricing. These factors should be considered carefully and readers are cautioned not to place undue reliance on such forward-looking statements. No assurance can be given that the future results covered by the forward...Boston Scientific Announces European Approval for Its LATITUDE(R) Patient Management System
...ss strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements. Factors that may cause such differences include, among ...Dr. Daniel Ronel Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
...s from across the United States who are experts in the field of injectable fillers. He was voted Albuquerque's Plastic Surgeon of the Year in 2007 by readers of The Herald, and was named one of Albuquerque's 2007 Top Docs by Albuquerque, the Magazine. He can be found on the web at www.danielronelmd.com ...Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors
...e Company's Annual Report on Form 10-K for the year ended December 31, 2008 and its Quarterly Report on Form 10-Q for the period ended March 31, 2009. readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The Company undertakes...EFSA Issues Positive Safety Statement for the Use of Chromium Picolinate in EU Food Supplements
...n forward-looking statements. The words "believe," "expect," "anticipate" and other similar expressions generally identify forward-looking statements. readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates. These forward-looking statements ar...Insmed Announces Results of IPLEX(TM) Phase II Trial in Myotonic Muscular Dystrophy
...ailed in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2008. readers are cautioned not to place undue reliance on any forward-looking statements which speak only as of the date of this release. We undertake no obligati...Spherix Announces Termination of Arla License Agreement
...llenges detailed in our filings with the U.S. Securities and Exchange Commission, including our current report on Form 8-K filed on October 10, 2007. readers are cautioned not to place undue reliance on any forward-looking statements which speak only as of the date of this release. We undertake no obligati...Spherix Announces Full-Scale Production of Pharmaceutical Tagatose
...llenges detailed in our filings with the U.S. Securities and Exchange Commission, including our current report on Form 8-K filed on October 10, 2007. readers are cautioned not to place undue reliance on any forward-looking statements which speak only as of the date of this release. We undertake no obligati...AFFiRiS AG: 1st Place in Venture Capital & Private Equity Awards for MIG Fonds and AFFiRiS
... and their co-sponsors Junge Industrie. The winners were chosen following a special selection process that combines the perspectives of the magazine's readers and selected experts, who evaluate corporate success stories from different perspectives. This year, an investment relationship that has been fruitful...Isolagen, Inc. Announces Receipt of Interim Order from Bankruptcy Court Approving DIP Motion
...ents as a prediction of actual results. We disclaim any intention to, and undertake no obligation to, update or revise any forward-looking statements. readers are also urged to carefully review and consider the other various disclosures in the Company's Annual Report on Form 10-K for the year ended December ...Quest Diagnostics Announces Final Tender Offer Results
...vailable at www.QuestDiagnostics.com . The statements in this press release which are not historical facts may be forward-looking statements. readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date that they are made and which reflect manageme...BioSyntech Reports Positive Results from Pivotal Trial for BST-CarGel(R) Cartilage Repair Device
...tractors and key personnel, and other risks and uncertainties detailed from time-to-time in our filings with the Canadian securities commissions. readers should not place undue reliance on the forward-looking information, given that (i) our actual results could differ materially from a conclusion, forec...Insmed CEO Resigns Due to Health Concerns
...ailed in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2008. readers are cautioned not to place undue reliance on any forward-looking statements which speak only as of the date of this release. We undertake no obligati...CardioDynamics Agrees to be Acquired by SonoSite for $1.35 Per Share
...re described in our filings with the SEC, including, without limitation, our Annual Report on Form 10-K and Quarterly Report on Form 10-Q. We caution readers not to place undue reliance upon these forward-looking statements that speak only as to the date of this release. We undertake no obligation to public...